As the global economy recovers in 2021 and the supply of the industrial chain improves, the Immuno-oncology Diagnosis market will undergo major changes. According to the latest research, the market size of the Immuno-oncology Diagnosis industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Immuno-oncology Diagnosis industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Immuno-oncology Diagnosis market during the next few years. The global Immuno-oncology Diagnosis market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Immuno-oncology Diagnosis market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America

Player list
10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioMrieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Protagen Diagnostics
Qiagen
Quanterix
Rarecells SAS
Roche Diagnostics
Siemens

Types list
PCR
NGS
Immunoassay

Application list
Research
Diagnostics